Get the Stockscreener App
2.79
4.30%
-0.12
Compass Therapeutics Inc stock is traded at $2.79, with a volume of 114.29K.
It is down -4.30% in the last 24 hours and up +5.49% over the past month.
Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to drug the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-IO Bispecific, and CTX-8371.
See More
Previous Close:
$2.91
Open:
$2.92
24h Volume:
114.29K
Relative Volume:
0.14
Market Cap:
$384.43M
Revenue:
-
Net Income/Loss:
$-45.44M
P/E Ratio:
-7.9714
EPS:
-0.35
Net Cash Flow:
$-42.28M
1W Performance:
-6.23%
1M Performance:
+5.49%
6M Performance:
-20.43%
1Y Performance:
+209.44%
1-Day Range:
$2.74
$2.92
1-Week Range:
$2.74
$3.03
52-Week Range:
$0.98
$4.08
Compass Therapeutics Inc Stock (CMPX) Company Profile
Name
Compass Therapeutics Inc
Sector
Industry
Phone
617-500-8099
Address
80 GUEST STREET, BOSTON
Compare CMPX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CMPX
Compass Therapeutics Inc
|
2.78 | 405.17M | 0 | -45.44M | -42.28M | -0.35 |
|
VRTX
Vertex Pharmaceuticals Inc
|
382.52 | 96.11B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.70 | 60.40B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
428.88 | 54.91B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
670.61 | 41.30B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
295.02 | 33.25B | 3.81B | -644.79M | -669.77M | -6.24 |
Compass Therapeutics Inc Stock (CMPX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-01-25 | Resumed | Raymond James | Outperform |
| Apr-02-25 | Upgrade | Leerink Partners | Market Perform → Outperform |
| Feb-24-25 | Initiated | Guggenheim | Buy |
| Feb-19-25 | Initiated | Piper Sandler | Overweight |
| Dec-23-24 | Initiated | D. Boral Capital | Buy |
| Nov-15-24 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Sep-16-24 | Upgrade | Ladenburg Thalmann | Neutral → Buy |
| Jan-31-23 | Initiated | Jefferies | Buy |
| Jan-27-23 | Initiated | Stifel | Buy |
| May-23-22 | Resumed | H.C. Wainwright | Buy |
| Mar-15-22 | Initiated | Ladenburg Thalmann | Buy |
| Jan-19-22 | Initiated | B. Riley Securities | Buy |
| Dec-22-21 | Initiated | Raymond James | Outperform |
| Dec-20-21 | Initiated | SVB Leerink | Outperform |
| Dec-15-21 | Initiated | Wedbush | Outperform |
View All
Compass Therapeutics Inc Stock (CMPX) Latest News
Earnings visualization tools for Compass Therapeutics Inc.Portfolio Positioning Strategy With Timing - Newser
Will Compass Therapeutics Inc. continue its uptrendFuture Growth Stock Forecasting Strategy - Newser
Compass Therapeutics Inc. stock prediction for this weekShort Term Gain Strategy with AI Logic - Newser
What makes Compass Therapeutics Inc. stock price move sharplyFree Consistent Gain Investment Strategies - Newser
Has Compass Therapeutics Inc. formed a bullish divergenceSmart Entry Signals for Active Traders - Newser
Is Compass Therapeutics Inc. forming a reversal patternIntraday Strategy with Real Time Monitoring - Newser
Using Ichimoku Cloud for Compass Therapeutics Inc. technicalsAI Trend Detection for Entry Timing - Newser
Detecting support and resistance levels for Compass Therapeutics Inc.Breakout Screener With Alert Based Timing - Newser
Heatmap analysis for Compass Therapeutics Inc. and competitorsFree Sector Based Breakout Stock Forecast - Newser
What does recent volatility data suggest for Compass Therapeutics Inc.Machine Learning Intraday Signal Forecast - Newser
Does Compass Therapeutics Inc. stock perform well during market downturnsDynamic growth stocks - Jammu Links News
How volatile is Compass Therapeutics Inc. stock compared to the marketInvest confidently with real-time updates - Jammu Links News
What are the latest earnings results for Compass Therapeutics Inc.Free Expert Stock Watchlist - Jammu Links News
What is the dividend policy of Compass Therapeutics Inc. stockUnlock powerful market trend analysis - Jammu Links News
What are analysts’ price targets for Compass Therapeutics Inc. in the next 12 monthsNavigate market shifts with confidence - Jammu Links News
What drives Compass Therapeutics Inc. stock priceAccelerated investment success - Jammu Links News
What institutional investors are buying Compass Therapeutics Inc. stockCapitalize on momentum-driven stocks - Jammu Links News
Is it the right time to buy Compass Therapeutics Inc. stockFree Stock Selection - Jammu Links News
Why is Compass Therapeutics Inc. stock attracting strong analyst attentionDynamic profit expansion - Jammu Links News
What are Compass Therapeutics Inc. company’s key revenue driversMarket-leading capital gains - Jammu Links News
When is the best time to exit Compass Therapeutics Inc.Short Term Opportunity Finder with Tools - Newser
Momentum divergence signals in Compass Therapeutics Inc. chartFree Fast Gaining Stock Screener Report - Newser
Price action breakdown for Compass Therapeutics Inc.Weekly Return Plan for Conservative Traders - Newser
Using data tools to time your Compass Therapeutics Inc. exitStrong Buy Signal Summary with Entry Zone - Newser
Can machine learning forecast Compass Therapeutics Inc. recoveryFree Low Volatility Stable Growth Picks - Newser
Is Compass Therapeutics Inc. stock a growth or value playLong-Term Safety Investment Analysis Report - Newser
Technical signs of recovery in Compass Therapeutics Inc.Bear Market Safe Zone Technical Analysis - Newser
What analysts say about Compass Therapeutics Inc. stock outlookFree AI-Powered Trade Planning with Indicators - Newser
Why Compass Therapeutics Inc. stock attracts strong analyst attentionSummary of Trade Cycles in 5-Year Range - Newser
Compass Therapeutics Inc. Rebound Backed by Sentiment ShiftAlpha Driven Watchlist With Alerts Published - metal.it
Can Compass Therapeutics Inc. Escape Recent Bear ChannelLow Risk High Return Opportunities Identified - metal.it
Published on: 2025-07-29 20:25:47 - metal.it
Is Compass Therapeutics Inc. a candidate for recovery playShort Term Opportunity Finder with Tools - Newser
Compass Therapeutics Inc. Rebounds From Oversold Zone — Now WhatEarly Breakout Entry Point Notifications Sent - metal.it
What is Compass Therapeutics Inc. company’s growth strategyFree Stock Trend Scanner For 2025 - jammulinksnews.com
Compass Therapeutics Inc Stock (CMPX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Compass Therapeutics Inc Stock (CMPX) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| GORDON CARL L | Director |
Apr 09 '25 |
Sale |
1.59 |
3,571,428 |
5,678,571 |
0 |
| ORBIMED ADVISORS LLC | Director |
Apr 09 '25 |
Sale |
1.59 |
3,571,428 |
5,678,571 |
0 |
0.54%
1.25%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):